Cite

HARVARD Citation

    Digklia, A. et al. (2022). First communication on the efficacy of combined 177Lutetium-PSMA with immunotherapy outside prostate cancer. Journal for immunotherapy of cancer. 10 (10), p. . [Online]. 
  
Back to record